LC-MS/MS analysis identified 25 peptides, predicted to possess antioxidative activity and additional benefits such as ACE and dipeptidyl peptidase IV (DPP IV) inhibition, suggesting potential applications in hypertension and diabetes management [184]. This evidence concerns the gene DPP4 and hypertensive disorder.